BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 12, 2011
 |  BC Week In Review  |  Company News  |  Deals

BTG, Ohara Pharma deal

BTG granted Ohara exclusive rights to develop and commercialize Voraxaze glucarpidase in Japan. BTG will supply the product to Ohara, which will be responsible for registration in...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >